类风湿性关节炎继发骨质疏松症患者的生命质量调查及慢性病管理

目的调查类风湿性关节炎继发骨质疏松症患者的生命质量,及考察采用慢性病管理的干预效果。方法纳入2013年8月至2016年2月我院风湿科治疗的类风湿性关节炎继发骨质疏松症患者158例作为研究对象。随机分为对照组76例与观察组76例。对照组予常规抗骨质疏松治疗,观察组在常规抗骨质疏松治疗基础上予慢性病管理。通过比较两组患者的类风湿性关节炎的类风湿因子血沉、C反应蛋白以及1年后复查骨密度情况。采用满意度调查以及视觉模拟评分法(VAS)评价患者慢性病管理质量及疼痛情况。结果干预前,两组骨质疏松及类风湿性关节炎观察指标无统计学差异性(P〉0.05);观察组干预后指标明显优于对照组;1年后复查骨密度,对照组...

Full description

Saved in:
Bibliographic Details
Published in中国骨质疏松杂志 Vol. 23; no. 9; pp. 1187 - 1190
Main Author 陈宇航 庄宇 叶石保 王志文 辛盼盼 吕志芬 张雪珍 谭志明
Format Journal Article
LanguageChinese
Published 惠州市中心人民医院,广东惠州,516001 2017
Subjects
Online AccessGet full text
ISSN1006-7108
DOI10.3969/j.issn.1006-7108.2017.09.015

Cover

More Information
Summary:目的调查类风湿性关节炎继发骨质疏松症患者的生命质量,及考察采用慢性病管理的干预效果。方法纳入2013年8月至2016年2月我院风湿科治疗的类风湿性关节炎继发骨质疏松症患者158例作为研究对象。随机分为对照组76例与观察组76例。对照组予常规抗骨质疏松治疗,观察组在常规抗骨质疏松治疗基础上予慢性病管理。通过比较两组患者的类风湿性关节炎的类风湿因子血沉、C反应蛋白以及1年后复查骨密度情况。采用满意度调查以及视觉模拟评分法(VAS)评价患者慢性病管理质量及疼痛情况。结果干预前,两组骨质疏松及类风湿性关节炎观察指标无统计学差异性(P〉0.05);观察组干预后指标明显优于对照组;1年后复查骨密度,对照组骨质疏松患者明显多于观察组(P〈0.05)。干预后,观察组患者疼痛评分明显低于对照组(P〈0.05),观察组患者的慢性病管理效果优于对照组(P〈0.05)。结论应用慢性病管理模式干预类风湿性关节炎继发骨质疏松症患者后,能有效减少关节疼痛,改善骨质疏松及类风湿性关节炎各项指标值,提高了患者的整体生命质量,值得临床广泛推广。
Bibliography:Arthritis; Secondary osteoporosis; Chronic disease management; Visual analogue scale
Objective To investigate the quality of life of patients with osteoporosis secondary to arthritis,and to investigate the intervention effect of chronic disease management. Methods A total of 158 patients with osteoporosis secondary to rheumatoid arthritis treated in our hospital from August 2013 to February 2016 were included in the study. The patients were divided into control group( 76 cases) and observation group( 76 cases). Patients in the control group received routine intervention. Patients in the observation group received chronic disease management on the basis of the control group. Erythrocyte sedimentation rate,C-reactive protein,and bone mineral density were compared between the two groups in 1 year. Satisfaction survey and visual analogue scale( VAS) were used to evaluate the quality of chronic disease and pain. Results There was no significant difference in rheumatoid arthritis parameters between the two groups be
ISSN:1006-7108
DOI:10.3969/j.issn.1006-7108.2017.09.015